Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients

NCT04102956 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Stroke, Acute

Interventions

DRUG: Kallikrein

Sponsor

The Second Hospital of Hebei Medical University